Prostate-Specific Antigen (PSA) response with darolutamide plus Androgen-Deprivation Therapy (ADT) in patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in ARANOTE

Fred Saad; K.P Haresh; N.S. Shore; Egils Vjaters; David Olmos; Natasha Littleton; Isabella Testa; Shankar Srinivasan; Frank Verholen; Alberto Briganti

doi:10.1016/j.eururo.2025.09.4126

Prostate-Specific Antigen (PSA) response with darolutamide plus Androgen-Deprivation Therapy (ADT) in patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in ARANOTE

Fred Saad
, K.P Haresh
, N.S. Shore
, Egils Vjaters
, David Olmos
, Natasha Littleton
, Isabella Testa
, Shankar Srinivasan
, Frank Verholen
, Alberto Briganti

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	GC11
Journal	European Urology
Volume	87
Issue number	Suppl.2
DOIs	https://doi.org/10.1016/j.eururo.2025.09.4126
Publication status	Published - Mar 2025
Externally published	Yes
Event	40th Annual EAU Congress - Madrid, Spain Duration: 21 Mar 2025 → 24 Mar 2025

Field of Science*

3.2 Clinical medicine

Publication Type*

3.4. Other publications in conference proceedings (including local)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2025.09.4126

Prostate-Specific AntigenFinal published version, 201 KB

Cite this

Saad, F., Haresh , K. P., Shore, N. S., Vjaters, E., Olmos, D., Littleton, N., Testa, I., Srinivasan, S., Verholen, F., & Briganti, A. (2025). Prostate-Specific Antigen (PSA) response with darolutamide plus Androgen-Deprivation Therapy (ADT) in patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in ARANOTE. European Urology, 87(Suppl.2), Article GC11 . https://doi.org/10.1016/j.eururo.2025.09.4126

@article{9fe485fca9ca4da0b5ab46661fe9af55,

title = "Prostate-Specific Antigen (PSA) response with darolutamide plus Androgen-Deprivation Therapy (ADT) in patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in ARANOTE",

author = "Fred Saad and K.P Haresh and N.S. Shore and Egils Vjaters and David Olmos and Natasha Littleton and Isabella Testa and Shankar Srinivasan and Frank Verholen and Alberto Briganti",

year = "2025",

month = mar,

doi = "10.1016/j.eururo.2025.09.4126",

language = "English",

volume = "87",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier B.V.",

number = "Suppl.2",

note = "40th Annual EAU Congress ; Conference date: 21-03-2025 Through 24-03-2025",

}

Saad, F, Haresh , KP, Shore, NS, Vjaters, E, Olmos, D, Littleton, N, Testa, I, Srinivasan, S, Verholen, F & Briganti, A 2025, 'Prostate-Specific Antigen (PSA) response with darolutamide plus Androgen-Deprivation Therapy (ADT) in patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in ARANOTE', European Urology, vol. 87, no. Suppl.2, GC11 . https://doi.org/10.1016/j.eururo.2025.09.4126

TY - JOUR

T1 - Prostate-Specific Antigen (PSA) response with darolutamide plus Androgen-Deprivation Therapy (ADT) in patients with Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) in ARANOTE

AU - Saad, Fred

AU - Haresh , K.P

AU - Shore, N.S.

AU - Vjaters, Egils

AU - Olmos, David

AU - Littleton, Natasha

AU - Testa, Isabella

AU - Srinivasan, Shankar

AU - Verholen, Frank

AU - Briganti, Alberto

PY - 2025/3

Y1 - 2025/3

U2 - 10.1016/j.eururo.2025.09.4126

DO - 10.1016/j.eururo.2025.09.4126

M3 - Meeting Abstract

SN - 0302-2838

VL - 87

JO - European Urology

JF - European Urology

IS - Suppl.2

M1 - GC11

T2 - 40th Annual EAU Congress

Y2 - 21 March 2025 through 24 March 2025

ER -